ERBB2 and breast carcinoma: The bioinformatic analysis of available data from BioPortal (http://www.bioportal.no/) suggests that FGFR1 gene alterations are as significant in breast cancer patients as alterations in other known drivers of breast cancer (e.g. HER2) [97].